T1	HMM 0 20	Age-related response
T2	HMM 113 132	efficacy and safety
T3	HMM 443 467	Anti-PRP antibody levels
T4	HMM 550 570	Immunoresponsiveness
T5	HMM 588 597	increased
T6	HMM 610 641	lower incidence of side effects
T7	HMM 747 803	well tolerated clinically and has greater immunogenicity
